soul trial oral semaglutide cardiovascular outcomes Safety and Benefits of in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6 Study Finds Oral Semaglutide Vastly

Semaglutide, the active ingredient in Wegovy, is a GLP-1 agonist that regulates appetite and blood sugar

Direct manufacturer pricing plus an integrated care model could remove a lot of friction for patients whove struggled to navigate coverage and affordability

Reduces fine lines and improves elasticity with adenosine

SchloteBNowotnyBSchaafLKleinbhlDSchmidtRTeuberJet al

Together, we can navigate this path towards better health, ensuring that you feel supported every step of the way

Alternative pharmacological options include phentermine-topiramate (Qsymia) and naltrexone-bupropion (Contrave), though these also carry cardiac considerations